• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前瞻性多中心监测发现,日本京都和滋贺地区临床分离的烟曲霉中存在具有 TR34/L98H 突变的唑类耐药烟曲霉。

Prospective multicenter surveillance of clinically isolated Aspergillus species revealed azole-resistant Aspergillus fumigatus isolates with TR34/L98H mutation in the Kyoto and Shiga regions of Japan.

机构信息

Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.

出版信息

Med Mycol. 2019 Nov 1;57(8):997-1003. doi: 10.1093/mmy/myz003.

DOI:10.1093/mmy/myz003
PMID:30690480
Abstract

The prevalence of azole-resistant Aspergillus fumigatus (ARAF) in Japan is unclear. We aimed to investigate the epidemiology of clinically isolated Aspergillus species and the frequency of azole resistance in Aspergillus species, particularly Aspergillus fumigatus, in the Kyoto and Shiga regions of Japan. Strains of clinically isolated Aspergillus species were prospectively collected from nine acute care hospitals. Species identification was performed by DNA sequence analysis, and all strains were subjected to antifungal susceptibility testing. Sequencing of the Aspergillus cyp51A gene and promoter region and genotyping by short tandem repeats were performed for ARAF isolates. A total of 149 strains were collected, and 130 strains were included for the subsequent analysis after the exclusion of duplicate isolates. The most commonly isolated species was Aspergillus fumigatus, accounting for 43.1% (56 isolates) overall, and seven (12.7%) of 55 strains of A. fumigatus were azole-resistant. Azole-resistance of other Aspergillus species were also found that two (22.2%) of nine strains of A. tubingensis and two (28.6%) of seven strains of A. flavus were azole-resistant. DNA sequence analysis of the ARAF strains revealed that two carried the cyp51A TR34/L98H mutation, one carried G448S, one carried M220I, and three had no relevant mutations (wild type). Genotyping and phylogenetic analyses showed that the TR34/L98H strains were clustered with the strains from the Netherlands and France. These data suggest the emergence of ARAF with TR34/L98H in Japan, and continuous surveillance will be important to identify trends in resistance.

摘要

日本的烟曲霉唑耐药(ARAF)流行情况尚不清楚。我们旨在研究日本京都和滋贺地区临床分离的曲霉属物种的流行病学以及曲霉属物种(尤其是烟曲霉)的唑类耐药频率。从 9 家急性护理医院前瞻性采集临床分离的曲霉属菌株。通过 DNA 序列分析进行物种鉴定,所有菌株均进行抗真菌药敏试验。对 ARAF 分离株进行曲霉 CYP51A 基因和启动子区测序和短串联重复序列基因分型。共采集了 149 株菌株,排除重复分离株后,有 130 株菌株纳入后续分析。最常分离的物种是烟曲霉,占总数的 43.1%(56 株),55 株烟曲霉中有 7 株(12.7%)为唑类耐药。还发现了其他曲霉属的唑类耐药,9 株烟管曲霉中有 2 株(22.2%),7 株黄曲霉中有 2 株(28.6%)为唑类耐药。对 ARAF 菌株的 DNA 序列分析显示,2 株携带 CYP51A TR34/L98H 突变,1 株携带 G448S,1 株携带 M220I,3 株无相关突变(野生型)。基因分型和系统发育分析表明,TR34/L98H 株与来自荷兰和法国的菌株聚类。这些数据表明,日本出现了具有 TR34/L98H 的 ARAF,持续监测对于识别耐药趋势非常重要。

相似文献

1
Prospective multicenter surveillance of clinically isolated Aspergillus species revealed azole-resistant Aspergillus fumigatus isolates with TR34/L98H mutation in the Kyoto and Shiga regions of Japan.前瞻性多中心监测发现,日本京都和滋贺地区临床分离的烟曲霉中存在具有 TR34/L98H 突变的唑类耐药烟曲霉。
Med Mycol. 2019 Nov 1;57(8):997-1003. doi: 10.1093/mmy/myz003.
2
Azole resistance in Aspergillus species in Southern Taiwan: An epidemiological surveillance study.台湾南部曲霉菌属中唑类耐药性:一项流行病学监测研究。
Mycoses. 2019 Dec;62(12):1174-1181. doi: 10.1111/myc.13008. Epub 2019 Oct 6.
3
Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatus Isolates from China.中国临床和环境烟曲霉分离株中唑类抗性的流行病学及分子特征
Antimicrob Agents Chemother. 2016 Sep 23;60(10):5878-84. doi: 10.1128/AAC.01005-16. Print 2016 Oct.
4
Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients.德国囊性纤维化患者分离的曲霉菌属中唑类耐药的流行情况及分子特征。
J Antimicrob Chemother. 2014 Jun;69(6):1533-6. doi: 10.1093/jac/dku009. Epub 2014 Jan 31.
5
Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.墨西哥烟曲霉中唑类耐药性和 Cyp51A 突变筛查。
J Antimicrob Chemother. 2019 Jul 1;74(7):2047-2050. doi: 10.1093/jac/dkz121.
6
Azole resistance in Aspergillus fumigatus. The first 2-year's Data from the Danish National Surveillance Study, 2018-2020.烟曲霉唑类耐药性。2018-2020 年丹麦全国监测研究的头两年数据。
Mycoses. 2022 Apr;65(4):419-428. doi: 10.1111/myc.13426. Epub 2022 Feb 8.
7
Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes.丹麦的耐唑类烟曲霉:基于实验室的耐药机制和基因型研究。
Clin Microbiol Infect. 2016 Jun;22(6):570.e1-9. doi: 10.1016/j.cmi.2016.04.001. Epub 2016 Apr 16.
8
Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.2010年至2014年从伊朗患者中分离出的烟曲霉TR34/L98H和TR46/Y121F/T289A阳性菌株的单核苷酸多态性定量分析用于快速检测
Antimicrob Agents Chemother. 2015 Nov 2;60(1):387-92. doi: 10.1128/AAC.02326-15. Print 2016 Jan.
9
Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran.伊朗 TR34/L98H 突变 CYP51A 基因的唑类耐药烟曲霉的环境研究。
Mycoses. 2013 Nov;56(6):659-63. doi: 10.1111/myc.12089. Epub 2013 May 14.
10
Determination of Azole Resistance and TR/L98H Mutations in Isolates of Aspergillus Section Fumigati from Turkish Cystic Fibrosis Patients.从土耳其囊性纤维化患者中分离的烟曲霉节丛梗孢种群的唑类药物耐药性和 TR/L98H 突变的测定。
Mycopathologia. 2018 Dec;183(6):913-920. doi: 10.1007/s11046-018-0297-y. Epub 2018 Sep 6.

引用本文的文献

1
New Challenges in the Diagnosis and Treatment of Primary Cutaneous Aspergillosis in Extensive Pediatric Burns.大面积小儿烧伤原发性皮肤曲霉病诊断与治疗中的新挑战
J Fungi (Basel). 2025 Apr 2;11(4):281. doi: 10.3390/jof11040281.
2
Trends of Azole-Resistant Aspergillus Fumigatus Susceptibility Over 12 Years from a German ECMM Excellence Center.来自德国欧洲医学真菌学联盟卓越中心的12年间烟曲霉对唑类药物耐药性的变化趋势
Mycopathologia. 2025 Apr 5;190(2):34. doi: 10.1007/s11046-025-00941-x.
3
Comprehensive Review of Environmental Surveillance for Azole-Resistant : A Practical Roadmap for Hospital Clinicians and Infection Control Teams.
唑类耐药环境监测综合综述:医院临床医生和感染控制团队实用路线图
J Fungi (Basel). 2025 Jan 25;11(2):96. doi: 10.3390/jof11020096.
4
The impact of climate change on the epidemiology of fungal infections: implications for diagnosis, treatment, and public health strategies.气候变化对真菌感染流行病学的影响:对诊断、治疗及公共卫生策略的启示
Ther Adv Infect Dis. 2025 Feb 11;12:20499361251313841. doi: 10.1177/20499361251313841. eCollection 2025 Jan-Dec.
5
Antifungal Treatment for Japanese Patients with Chronic Pulmonary Aspergillosis.日本慢性肺曲霉病患者的抗真菌治疗
Infect Dis Ther. 2025 Jan;14(1):245-259. doi: 10.1007/s40121-024-01094-y. Epub 2024 Dec 26.
6
Aspergillus fumigatus-a systematic review to inform the World Health Organization priority list of fungal pathogens.烟曲霉——为世界卫生组织真菌病原体优先排序提供信息的系统综述。
Med Mycol. 2024 Jun 27;62(6). doi: 10.1093/mmy/myad129.
7
Epidemiology and Azole Resistance of Clinical Isolates of from a Large Tertiary Hospital in Ningxia, China.中国宁夏某大型三级医院临床分离株的流行病学及唑类耐药性
Infect Drug Resist. 2024 Feb 2;17:427-439. doi: 10.2147/IDR.S440363. eCollection 2024.
8
Genomic Epidemiology Identifies Azole Resistance Due to TR/L98H in European Causing COVID-19-Associated Pulmonary Aspergillosis.基因组流行病学确定欧洲因TR/L98H导致的唑类耐药与新冠肺炎相关肺曲霉病有关。
J Fungi (Basel). 2023 Nov 13;9(11):1104. doi: 10.3390/jof9111104.
9
Treatment of Invasive Aspergillosis: How It's Going, Where It's Heading.侵袭性曲霉病的治疗:现状与展望。
Mycopathologia. 2023 Oct;188(5):667-681. doi: 10.1007/s11046-023-00727-z. Epub 2023 Apr 26.
10
A Whole Genome Sequencing-Based Approach to Track down Genomic Variants in Itraconazole-Resistant Species of from Iran.一种基于全基因组测序的方法来追踪伊朗伊曲康唑耐药菌种中的基因组变异。
J Fungi (Basel). 2022 Oct 17;8(10):1091. doi: 10.3390/jof8101091.